Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026)

Fortrea Holdings (FTRE) reported Total Current Liabilities of $929.1 million for Q1 2026, down 7.01% on a YoY basis from $999.1 million in Q1 2025, and up 1.73% quarter-over-quarter from $913.3 million in Q4 2025.

Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Total Current Liabilities for 5 years, with the latest figure at $929.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 7.01% year-over-year to $929.1 million; the trailing twelve-month figure through Mar 2026 stood at $929.1 million (down 7.01% YoY), and the FY2025 full-year result was $913.3 million, down 3.81% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $929.1 million, up from $913.3 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $999.1 million in Q1 2025, with the low at $699.0 million in Q4 2022.
  • Historically, Total Current Liabilities has averaged $847.3 million across 5 years, with a median of $818.3 million in 2024.
  • Annual changes were most pronounced in 2025 — Total Current Liabilities climbed 25.81% — and 2026, when it slipped 7.01%.
  • Fortrea Holdings' Total Current Liabilities stood at $699.0 million in 2022, then increased by 11.36% to $778.4 million in 2023, then grew by 21.98% to $949.5 million in 2024, then retreated by 3.81% to $913.3 million in 2025, then grew by 1.73% to $929.1 million in 2026.
  • The last three Total Current Liabilities figures came in at $929.1 million (Q1 2026), $913.3 million (Q4 2025), and $914.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 929.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 929.10 Mn
Dec 31, 2025 913.30 Mn
Sep 30, 2025 914.40 Mn
Jun 30, 2025 942.30 Mn
Mar 31, 2025 999.10 Mn
Dec 31, 2024 949.50 Mn
Sep 30, 2024 795.80 Mn
Jun 30, 2024 749.00 Mn
Mar 31, 2024 818.30 Mn
Dec 31, 2023 778.40 Mn
Sep 30, 2023 774.60 Mn
Jun 30, 2023 752.10 Mn
Dec 31, 2022 699.00 Mn